logo
#

Latest news with #ThomasO'Malley

Nvidia-Backed SandboxAQ Introduces New AI Medical Data
Nvidia-Backed SandboxAQ Introduces New AI Medical Data

Business Insider

timea day ago

  • Business
  • Business Insider

Nvidia-Backed SandboxAQ Introduces New AI Medical Data

SandboxAQ, an artificial intelligence (AI) startup backed by Nvidia (NVDA), released new data today that could help drug makers develop new medicines. This data includes details on how drugs connect to proteins, which could help scientists better determine the effectiveness of a treatment. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Interestingly, this data doesn't come from years of lab research. Instead, SandboxAQ produced it with the help of Nvidia's processors. This allowed it to create simulated synthetic molecules based on real-world data. SandboxAQ believes the information gleaned from these virtual tests of proteins will assist with training AI models. These models could then aid scientists as they research new medical treatments. Nadia Harhen, general manager of AI simulation at SandboxAQ, told Reuters that this will allow researchers to 'use the synthetic data in a way that's never been done before.' What Does This Mean for Nvidia? First off, Nvidia is already a backer of SandboxAQ, meaning it wants to see the company succeed. The introduction of new data to train AI models is a boon to NVDA, as it is the world's leading provider of graphics processing units (GPUs) used in AI servers. The more uses there are for AI, the higher the demand for AI servers. That will also push demand for Nvidia's products higher, boosting its business and potentially further securing its dominance in the AI sector. Recent analyst coverage backs up this idea. Five-star Barclays analyst Thomas O'Malley reiterated a Buy rating and increased his price target for NVDA stock to $200 from $170, suggesting a 38.77% upside. Is Nvidia Stock a Buy, Sell, or Hold? average NVDA stock price target of $173.19, representing a potential 20.17% upside for the shares.

‘Nvidia Stock Is Heading to $200,' Says Top-Rated Analyst
‘Nvidia Stock Is Heading to $200,' Says Top-Rated Analyst

Business Insider

time3 days ago

  • Business
  • Business Insider

‘Nvidia Stock Is Heading to $200,' Says Top-Rated Analyst

Nvidia (NVDA) just got a fresh vote of confidence from Wall Street. Indeed, top-rated analyst Thomas O'Malley at Barclays has raised his price target on the AI chip giant from $170 to $200 while maintaining a Buy rating. With NVDA shares already on a powerful run in 2025, the new target suggests that there could still be plenty of upside ahead. Confident Investing Starts Here: Here's Why Barclays Is More Bullish on Nvidia Barclays' new price target implies a potential upside of 39% from current levels, which is significantly higher than the Wall Street average of almost 20%. The price target increase is largely based on strong supply chain demand, which suggests strong performance in the second half of the year. Interestingly, after reviewing Nvidia's supply chain following its Q1 earnings, Barclays spotted around $2 billion in potential upside for July compared to Wall Street expectations. As a result, the firm raised its full-year Compute revenue forecast to $37 billion, up from $35.6 billion. For context, compute revenue forecast estimates how much a company expects to earn from its computing products or services over a time period. Barclays also noted that Nvidia's new Blackwell chips hit 30,000 wafers per month in June, which is below its earlier estimate of 40,000. However, the firm noted that factory usage remains strong, and the overall tone of the supply chain is optimistic for the second half of the year. That gives Barclays more confidence in Nvidia's performance for October. Furthermore, analysts at Barclays highlighted that system sales are gaining momentum and are expected to make up around 25% of revenue in July and around 50% by October. What Is the 12-month Price Target for Nvidia? According to TipRanks, NVDA stock has a Strong Buy consensus rating based on 35 Buys, four Holds, and one Sell assigned in the last three months. At $172.36, the Nvidia share price target implies a 19.7% upside potential.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store